Article Preview:  Pfizer Requests FDA Authorization for COVID-19 Vaccine for Children 6 Months to 5 Years Old

Pfizer Requests FDA Authorization for COVID-19 Vaccine for Children 6 Months to 5 Years Old

Pfizer asked the FDA on Wednesday to authorize three doses of their COVID-19 vaccine for children between the...

Human Events Staff June 2, 2022
Article Preview:  CDC Recommends Children Ages 5 to 11 Receive Pfizer Booster

CDC Recommends Children Ages 5 to 11 Receive Pfizer Booster

The CDC advisory committee voted Thursday to recommend that children ages 5 to 11 receive the Pfizer COVID-19...

Human Events Staff May 20, 2022
Article Preview:  FDA Authorizes Pfizer Booster for Kids Ages 5 to 11

FDA Authorizes Pfizer Booster for Kids Ages 5 to 11

The FDA on Tuesday announced it will now allow the use of a single booster dose for children ages 5 to...

Human Events Staff May 17, 2022
Article Preview:  Moderna Requests FDA Authorization on COVID-19 Vaccine for Kids Under 6

Moderna Requests FDA Authorization on COVID-19 Vaccine for Kids Under 6

Moderna on Thursday requested the FDA authorize its COVID-19 vaccine for children under six.  The FDA is...

Human Events Staff April 28, 2022
Article Preview:  Pfizer Seeks Emergency Use Authorization for Booster for Kids 5 to 11

Pfizer Seeks Emergency Use Authorization for Booster for Kids 5 to 11

Pfizer on Tuesday requested the FDA approve an emergency use authorization for a booster shot for kids...

Human Events Staff April 27, 2022
Article Preview:  Moderna Requests Emergency Use Authorization for Second COVID Booster

Moderna Requests Emergency Use Authorization for Second COVID Booster

Moderna asked the FDA for emergency authorization of a second COVID-19 booster shot.  The company...

Human Events Staff March 18, 2022
Article Preview:  Pfizer Seeks Authorization for Second COVID-19 Booster

Pfizer Seeks Authorization for Second COVID-19 Booster

Pfizer and BioNTech on Tuesday requested U.S. regulators to authorize a second COVID-19 booster for...

Human Events Staff March 16, 2022
Article Preview:  Twitter Suspends Just the News CEO John Solomon…For WHAT?

Twitter Suspends Just the News CEO John Solomon…For WHAT?

Twitter on Thursday suspended Just the News CEO and editor John Solomon for tweeting a story about a...

Brent Hamachek March 4, 2022
Article Preview:  FDA Weighing Approval of SECOND Booster Shot

FDA Weighing Approval of SECOND Booster Shot

The FDA signaled their intent to approve a second COVID-19 booster.  Alison Hunt, a spokesperson for the...

Human Events Staff February 21, 2022
Article Preview:  Pfizer to Delay FDA Vaccine Authorization for Children Under 5

Pfizer to Delay FDA Vaccine Authorization for Children Under 5

Pfizer on Friday said it’s delaying its FDA vaccine authorization request for children under five years old...

Human Events Staff February 11, 2022
Article Preview:  Pfizer Asks FDA to Approve COVID-19 Vaccine for Children Under Five

Pfizer Asks FDA to Approve COVID-19 Vaccine for Children Under Five

Pfizer asked the FDA on Tuesday to approve their COVID-19 vaccine for children under the age of five.  As...

Human Events Staff February 2, 2022
Article Preview:  Britain to Make Pfizer COVID-19 Pill Available in February

Britain to Make Pfizer COVID-19 Pill Available in February

Great Britain will begin the rollout of the Pfizer COVID-19 pill in February, the United Kingdom Department...

Human Events Staff January 28, 2022
Article Preview:  Moderna Begins Study on Omicron-Specific Booster

Moderna Begins Study on Omicron-Specific Booster

Moderna announced Wednesday that it began the first study of an omicron-specific booster. The company said...

Human Events Staff January 27, 2022
Article Preview:  Pfizer COVID-19 Antiviral Pill Effective Against Omicron

Pfizer COVID-19 Antiviral Pill Effective Against Omicron

Pfizer announced Tuesday that its COVID-19 pill, Paxlovid, is effective against the omicron variant.  The...

Human Events Staff January 18, 2022